BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · IEX Real-Time Price · USD
1.110
+0.080 (7.77%)
At close: Mar 27, 2024, 4:00 PM
1.100
-0.010 (-0.90%)
Pre-market: Mar 28, 2024, 4:30 AM EDT

BioLineRx Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2009
Revenue
4.8000000000
Upgrade
Cost of Revenue
3.69000000000
Upgrade
Gross Profit
1.11000000000
Upgrade
Selling, General & Admin
31.5811.535.314.754.675.85.735.344.715.39
Upgrade
Research & Development
12.5217.6319.4718.1723.4419.8119.5111.1811.4911.87
Upgrade
Other Operating Expenses
6.7000000000
Upgrade
Operating Expenses
50.829.1624.7822.9328.1125.6125.2416.5116.217.26
Upgrade
Operating Income
-49.69-29.16-24.78-22.93-28.11-25.61-25.24-16.51-16.2-17.26
Upgrade
Interest Expense / Income
2.172.161.011.632.280.470.020.020.110.45
Upgrade
Other Expense / Income
8.75-6.361.275.47-4.94-3.12-0.91-0.69-1.9-6.63
Upgrade
Pretax Income
-60.61-24.95-27.05-30.02-25.45-22.96-24.35-15.84-14.4-11.08
Upgrade
Net Income
-60.61-24.95-27.05-30.02-25.45-22.96-24.35-15.84-14.4-11.08
Upgrade
Shares Outstanding (Basic)
96377466325314610990565132
Upgrade
Shares Outstanding (Diluted)
96377466325314610990565132
Upgrade
Shares Change
24.47%16.75%162.19%72.70%34.82%20.70%60.25%9.22%58.50%44.22%
Upgrade
EPS (Basic)
-0.06-0.03-0.04-0.12-0.17-0.21-0.27-0.28-0.28-0.34
Upgrade
EPS (Diluted)
-0.06-0.03-0.04-0.12-0.17-0.21-0.27-0.28-0.28-0.34
Upgrade
Free Cash Flow
-22.72-26.37-23.67-23.21-22.73-24.37-20.89-14.57-16.85-15.94
Upgrade
Free Cash Flow Per Share
-0.35-0.51-0.54-1.38-2.33-3.37-3.48-3.89-4.92-7.37
Upgrade
Gross Margin
23.08%---------
Upgrade
Operating Margin
-1035.29%---------
Upgrade
Profit Margin
-1262.79%---------
Upgrade
Free Cash Flow Margin
-473.42%---------
Upgrade
EBITDA
-57.06-22.14-25.35-27.46-22.23-21.94-23.85-15.34-13.85-10.36
Upgrade
EBITDA Margin
-1188.77%---------
Upgrade
Depreciation & Amortization
1.380.650.70.930.940.550.480.480.440.27
Upgrade
EBIT
-58.45-22.79-26.05-28.39-23.17-22.49-24.33-15.82-14.29-10.63
Upgrade
EBIT Margin
-1217.60%---------
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).